CoChat

Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction

Open access

Published version of a preprint

The DOI matches its Crossref record; 80 of the 82 references it cites were found in a registry or an index.

Abstract

Context: Body fat distribution is a risk factor for obesity-associated comorbidities, and adipose tissue dysfunction plays a role in this association. In humans, there is a sex difference in body fat distribution, and steroid hormones are known to regulate several cellular processes within adipose tissue. Objective: Our aim was to investigate if intra-adipose steroid concentration and expression or activity of steroidogenic enzymes were associated with features of adipose tissue dysfunction in individuals with severe obesity. Methods: Samples from 40 bariatric candidates (31 women, 9 men) were included in the study. Visceral (VAT) and subcutaneous adipose tissue (SAT) were collected during surgery. Adipose tissue morphology was measured by a combination of histological staining and semi-automated quantification. Following extraction, intra-adipose and plasma steroid concentrations were determined by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). Aromatase activity was estimated using product over substrate ratio, while AKR1C2 activity was measured directly by fluorogenic probe. Gene expression was measured by quantitative PCR. Results: VAT aromatase activity was positively associated with VAT adipocyte hypertrophy (P valueadj < 0.01) and negatively with plasma high-density lipoprotein (HDL)-cholesterol (P valueadj < 0.01), while SAT aromatase activity predicted dyslipidemia in women even after adjustment for waist circumference, age, and hormonal contraceptive use. We additionally compared women with high and low visceral adiposity index (VAI) and found that VAT excess is characterized by adipose tissue dysfunction, increased androgen catabolism mirrored by increased AKR1C2 activity, and higher aromatase expression and activity indices. Conclusion: In women, increased androgen catabolism or aromatization is associated with visceral adiposity and adipose tissue dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgac261

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Features of adipose tissue dysfunction. Differences in mean adipocyte diameter (μm) (N = 26, SAT vs N = 27, VAT) (A), pericellular fibrosis (%) (N = 27, SAT vs N = 29, VAT) (B) and the expression of DGAT2 (N = 30, SAT vs N = 30, VAT), implicated in triglyceride biosynthesis, and GPX3 (N = 30, SAT vs N = 30, VAT), associated with lower intracellular reactive oxygen species (ROS) production (C) in SAT and VAT. Pearson correlation coefficient range and P values (D) for untransformed and log10-transformed (#) variables. Correlations with HbA1c were assessed with Spearman’s rank coefficients. The gray intensity reflects the strength of the correlation (Pearson’s r or Spearman’s rho), strong positive associations are illustrated in black while strong negative association in white.
Figure 1. Features of adipose tissue dysfunction. Differences in mean adipocyte diameter (μm) (N = 26, SAT vs N = 27, VAT) (A), pericellular fibrosis (%) (N = 27, SAT vs N = 29, VAT) (B) and the expression of DGAT2 (N = 30, SAT vs N = 30, VAT), implicated in triglyceride biosynthesis, and GPX3 (N = 30, SAT vs N = 30, VAT), associated with lower intracellular reactive oxygen species (ROS) production (C) in SAT and VAT. Pearson correlation coefficient range and P values (D) for untransformed and log10-transformed (#) variables. Correlations with HbA1c were assessed with Spearman’s rank coefficients. The gray intensity reflects the strength of the correlation (Pearson’s r or Spearman’s rho), strong positive associations are illustrated in black while strong negative association in white.CC BY · PubMed Central
Figure 2. Comparison between women with high vs low visceral adipose index (VAI) in terms of adipose tissue dysfunction markers, steroid hormone concentrations and mRNA expression measurements. Differences WC (A), SAT (low VAI, N = 9 vs high VAI, N = 17) (B) and VAT (low VAI, N = 10 vs high VAI, N = 17) (C) mean adipocyte diameter (μm), VAT testosterone (low VAI, N = 12) (D), androstenedione (high VAI, N = 17) (E) concentrations and comparison with aromatase activity indices (F), (low VAI, N = 12 vs high VAI, N = 16) (G), (high VAI, N = 17) (H), (low VAI, N = 11 vs high VAI, N = 16) (I), and AKR1C2 (low VAI, N = 11 vs high VAI, N = 17) enzymatic activity (J). Differences in plasma estradiol (high VAI, N = 17) (K), and apolipoprotein B (L) as well as intra-adipose gene expression of DGAT2 (SAT: high VAI, N = 17; VAT: low VAI, N = 12), GPX3 (SAT: high VAI, N = 17; VAT: low VAI, N = 12), AKR1C3 (SAT: high VAI, N = 17; VAT: low VAI, N = 12 vs high VAI, N = 17), AKR1C2 (SAT: high VAI, N = 17; VAT: low VAI, N = 12 vs low VAI = 17), CYP19A1 (SAT: high VAI, N = 17; VAT: low VAI, N = 10 vs low VAI = 16) and HSD11B1 (SAT: high VAI, N = 17; VAT: low VAI, N = 12 vs low VAI = 17) (M). Low VAI; N = 13 vs high VAI, N = 18 unless otherwise stated.
Figure 2. Comparison between women with high vs low visceral adipose index (VAI) in terms of adipose tissue dysfunction markers, steroid hormone concentrations and mRNA expression measurements. Differences WC (A), SAT (low VAI, N = 9 vs high VAI, N = 17) (B) and VAT (low VAI, N = 10 vs high VAI, N = 17) (C) mean adipocyte diameter (μm), VAT testosterone (low VAI, N = 12) (D), androstenedione (high VAI, N = 17) (E) concentrations and comparison with aromatase activity indices (F), (low VAI, N = 12 vs high VAI, N = 16) (G), (high VAI, N = 17) (H), (low VAI, N = 11 vs high VAI, N = 16) (I), and AKR1C2 (low VAI, N = 11 vs high VAI, N = 17) enzymatic activity (J). Differences in plasma estradiol (high VAI, N = 17) (K), and apolipoprotein B (L) as well as intra-adipose gene expression of DGAT2 (SAT: high VAI, N = 17; VAT: low VAI, N = 12), GPX3 (SAT: high VAI, N = 17; VAT: low VAI, N = 12), AKR1C3 (SAT: high VAI, N = 17; VAT: low VAI, N = 12 vs high VAI, N = 17), AKR1C2 (SAT: high VAI, N = 17; VAT: low VAI, N = 12 vs low VAI = 17), CYP19A1 (SAT: high VAI, N = 17; VAT: low VAI, N = 10 vs low VAI = 16) and HSD11B1 (SAT: high VAI, N = 17; VAT: low VAI, N = 12 vs low VAI = 17) (M). Low VAI; N = 13 vs high VAI, N = 18 unless otherwise stated.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 80 references

Cited by

See all 30

Metadata

Authors
Ostinelli, G., Laforest, S., Denham, S. G., Gauthier, M.-F., Drolet-Labelle, V., Scott, E., Hould, F.-S., Marceau, S., Homer, N. Z. M., Bégin, C., Andrew, R., & Tchernof, A.
Affiliations
  • Institut universitaire de cardiologie et de pneumologie de Québec (CA)
  • University of Strathclyde (GB)
  • The Queen's Medical Research Institute (GB)
  • Centre de recherche de l’Institut universitaire de cardiologie et pneumologie de Québec-Université Laval , Québec City, QC G1V 4G5 , Canada
  • Université Laval (CA)
Corresponding author
Tchernof, André
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2022-05-03
Volume
107
Issue
8
Pages
e3330-e3342
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4229033140
Cited by
30
References
82
Citations by year
2026: 7 · 2025: 9 · 2024: 4 · 2023: 8 · 2022: 2
FWCI
4.15
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • Foundation of the Quebec Heart and Lung Institute - Laval University
  • CIHR (PJT-169083)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
adipose tissue dysfunction, aromatase activity, AKR1C2, visceral adipose tissue, subcutaneous adipose tissue, visceral adiposity index, body fat distribution, sex differences, dyslipidemia, HDL cholesterol, adipocyte hypertrophy, steroidogenic enzymes, morbid obesity, women, bariatric surgery
MeSH terms
Adipose Tissue, Androgens, Aromatase, Female, Humans, Male, Obesity, Morbid, Gonadal Steroid Hormones, Body Mass Index, Intra-Abdominal Fat, Body Fat Distribution, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction. https://app.cochat.ai/papers/10.1210/clinem/dgac261
The paper
Ostinelli, G., Laforest, S., Denham, S. G., Gauthier, M.-F., Drolet-Labelle, V., Scott, E., Hould, F.-S., Marceau, S., Homer, N. Z. M., Bégin, C., Andrew, R., & Tchernof, A. (2022). Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac261

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.